Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes

10.1016/j.jacc.2021.04.079

Saved in:

Bibliographic Details
Main Authors:	Filippatos, Gerasimos, Bakris, George L., Pitt, Bertram, Agarwal, Rajiv, Rossing, Peter, Ruilope, Luis M., Butler, Javed, Lam, Carolyn S. P., Kolkhof, Peter, Roberts, Luke, Tasto, Christoph, Joseph, Amer, Anker, Stefan D., FIDELIO-DKD Investigators.
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	Elsevier Inc. 2022
Subjects:	chronic kidney disease clinical trial finerenone mineralocorticoid receptor antagonist new-onset atrial fibrillation type 2 diabetes
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/232604
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-232604
record_format	dspace
spelling	sg-nus-scholar.10635-2326042023-09-08T09:25:26Z Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes Filippatos, Gerasimos Bakris, George L. Pitt, Bertram Agarwal, Rajiv Rossing, Peter Ruilope, Luis M. Butler, Javed Lam, Carolyn S. P. Kolkhof, Peter Roberts, Luke Tasto, Christoph Joseph, Amer Anker, Stefan D. FIDELIO-DKD Investigators. DUKE-NUS MEDICAL SCHOOL chronic kidney disease clinical trial finerenone mineralocorticoid receptor antagonist new-onset atrial fibrillation type 2 diabetes 10.1016/j.jacc.2021.04.079 Journal of the American College of Cardiology 78 2 142-152 2022-10-12T08:16:04Z 2022-10-12T08:16:04Z 2021-07-01 Article Filippatos, Gerasimos, Bakris, George L., Pitt, Bertram, Agarwal, Rajiv, Rossing, Peter, Ruilope, Luis M., Butler, Javed, Lam, Carolyn S. P., Kolkhof, Peter, Roberts, Luke, Tasto, Christoph, Joseph, Amer, Anker, Stefan D., FIDELIO-DKD Investigators. (2021-07-01). Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes. Journal of the American College of Cardiology 78 (2) : 142-152. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jacc.2021.04.079 0735-1097 https://scholarbank.nus.edu.sg/handle/10635/232604 Attribution-NonCommercial-NoDerivatives 4.0 International https://creativecommons.org/licenses/by-nc-nd/4.0/ Elsevier Inc. Scopus OA2021
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	chronic kidney disease clinical trial finerenone mineralocorticoid receptor antagonist new-onset atrial fibrillation type 2 diabetes
spellingShingle	chronic kidney disease clinical trial finerenone mineralocorticoid receptor antagonist new-onset atrial fibrillation type 2 diabetes Filippatos, Gerasimos Bakris, George L. Pitt, Bertram Agarwal, Rajiv Rossing, Peter Ruilope, Luis M. Butler, Javed Lam, Carolyn S. P. Kolkhof, Peter Roberts, Luke Tasto, Christoph Joseph, Amer Anker, Stefan D. FIDELIO-DKD Investigators. Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
description	10.1016/j.jacc.2021.04.079
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Filippatos, Gerasimos Bakris, George L. Pitt, Bertram Agarwal, Rajiv Rossing, Peter Ruilope, Luis M. Butler, Javed Lam, Carolyn S. P. Kolkhof, Peter Roberts, Luke Tasto, Christoph Joseph, Amer Anker, Stefan D. FIDELIO-DKD Investigators.
format	Article
author	Filippatos, Gerasimos Bakris, George L. Pitt, Bertram Agarwal, Rajiv Rossing, Peter Ruilope, Luis M. Butler, Javed Lam, Carolyn S. P. Kolkhof, Peter Roberts, Luke Tasto, Christoph Joseph, Amer Anker, Stefan D. FIDELIO-DKD Investigators.
author_sort	Filippatos, Gerasimos
title	Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
title_short	Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
title_full	Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
title_fullStr	Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
title_full_unstemmed	Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
title_sort	finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes
publisher	Elsevier Inc.
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/232604
_version_	1779155073535836160

Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes

Similar Items